Most recent CPS Statements Flashcards
What are the most common causes of pneumonia in children?
- Viral: Influenza, parainfluenza, RSV, HMPV 2. Bacterial: Strep pneumo, GAS, Chlamydia pneum, mycoplasma
What is the typical presentation of mycoplasma pneumonia?
Malaise and headache for seven to 10 days before the onset of fever and cough
What is the approach to antibiotic coverage in pneumonia?
Outpt: amoxicillin Inpt: ampicillin Respiratory failure or septic shock: Ceftriaxone or cefotaxime +/- vancomycin
What is the approach to treatment of mycoplasma pneumonia?
-Could potentially self-resolve -Treatment may hasten recovery -Macrolide (azithromycin) x 5 days -If resistance and >8: doxycycline
What is the standard length of therapy for uncomplicated pneumonia?
Seven to ten days
What is the approach to non-anaphylaxtic reactions to penicillin?
If a patient experienced a nonurticarial rash after previous use of a penicillin or amoxicillin, they can safely be started on ampicillin or amoxicillin therapy. X-reaction with cephalosporins is extremely low
Which terms should no longer be used regarding wheezing in preschoolers?
‘bronchospasm’ ‘reactive airway disease’ ‘wheezy bronchitis’ ‘happy wheezer’
Does recurrent preschool wheeze matter?
-can be associated with substantial morbidity and may impact long-term health
What are the new criteria for diagnosis of asthma between 1-5 years of age?
How does bronchiolitis present?
-The first episode of wheezing in a child <1 year of age.
In a child one to five years of age with recurrent (≥2) episodes of asthma-like symptoms and wheezing on presentation, what confirms the diagnosis of asthma?
Direct observation of improvement with inhaled bronchodilator (with or without oral corticosteroids) by a physician or trained health care practitioner confirms the diagnosis (preferred diagnostic method)
Children one to five years of age with recurrent (≥2) episodes of asthma-like symptoms, no wheezing on presentation, what confirms the diagnosis of asthma?
- frequent symptoms or any moderate or severe exacerbation warrant a three-month therapeutic trial with a medium daily dose of ICS (with as-needed SABA)
- Clear consistent improvement in the frequency and severity of symptoms and/or exacerbations confirms the diagnosis (alternative diagnostic method).
Children one to five years of age with recurrent (≥2) episodes of asthma-like symptoms, no wheezing on presentation, infrequent symptoms, and mild exacerbations, what confirms the diagnosis of asthma?
-Can be monitored and re-assessed by a health care practitioner when symptomatic. Alternatively, a therapeutic trial with as-needed SABA is suggested. Convincing parental report of a rapid and repeatedly observed response to SABA suggests the diagnosis (weaker alternative diagnostic method)
When is a referral to an asthma specialist suggested in children 1-5 years?
- Diagnostic uncertainty
- Suspicion of comorbidity
- Poor symptom and exacerbation control despite ICS at daily doses of 200 µg to 250 µg
- ife-threatening event (requiring intensive care admission and/or intubation)
- for allergy testing to assess the possible role of environmental allergens
For children 1-3 years of age, what is the recommended delivery of puffers?
-a spacer with a correctly sized facemask is preferred.
For children 4-5 years, what delivery method is recommended for puffers?
-consideration to use a spacer with a mouthpiece is encouraged if the child can form a good seal around the mouthpiece and breathe in through the mouth as observed by a trained health care professional.
What is first line asthma therapy when the diagnosis is made?
-Daily ICS at the lowest effective dose
Who should receive influenza vaccination?
ALL children and youth ≥6 months of age
What groups should be given priority for influenza vaccination?
Cardiac or pulmonary disorders including bronchopulmonary dysplasia, cystic fibrosis, asthma or conditions associated with an increased risk for aspiration
Diabetes mellitus and other metabolic diseases
Renal disease
Anemia or hemoglobinopathy
Cancer or other immune-compromising conditions (due to disease or therapy)
Morbid obesity (body mass index ≥40 kg/m2)
Children and adolescents (six months to 18 years of age) with neurological or neurodevelopmental conditions (including seizure disorders, febrile seizures and isolated developmental delay)
Children and adolescents (six months to 18 years of age) with a chronic condition currently undergoing prolonged treatment with acetylsalicylic acid
What are the two types of influenza vaccines that are available in Canada?
inactivated influenza vaccines (IIV) for intramuscular injection and an intranasal, live attenuated influenza vaccine (LAIV).
Who can be given the LAIV for influenza vaccination?
It is authorized for use in individuals two to 59 years of age.[2] LAIV is not licensed for use in children <2 years of age because of a small, but significant, increased rate of wheezing two to four weeks following vaccination observed in this age group
In what group is the LAIV recommended?
children two to six years of age because of its greater efficacy
an expected higher acceptance of intranasal administration compared with injection
What are the contraindications for influenza vaccine?
An anaphylactic reaction to a previous dose of influenza vaccine or onset of Guillain-Barré syndrome within six weeks of influenza vaccination are contraindications
Is an EGG allergy a contraindication to the influenza vaccine?
No